Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
Authors
Keywords
-
Journal
ADVANCES IN THERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-02-17
DOI
10.1007/s12325-020-01251-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prophylactic Therapy of Silymarin (Milk Thistle) on Antituberculosis Drug-Induced Liver Injury: A Meta-Analysis of Randomized Controlled Trials
- (2019) Lina Tao et al. Canadian Journal of Gastroenterology and Hepatology
- Oxidative Stress and Antioxidant Biomarkers in Clinical and Experimental Models of Non-Alcoholic Fatty Liver Disease
- (2019) Ayokanmi Ore et al. Medicina-Lithuania
- EASL Clinical Practice Guidelines: Management of alcohol-related liver disease
- (2018) Mark Thursz et al. JOURNAL OF HEPATOLOGY
- The use of SAMe in chemotherapy-induced liver injury
- (2018) B. Vincenzi et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Burden of Liver Diseases in the World
- (2018) Sumeet K. Asrani et al. JOURNAL OF HEPATOLOGY
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- The interplay of IKK, NF-κB and RIPK1 signaling in the regulation of cell death, tissue homeostasis and inflammation
- (2017) Vangelis Kondylis et al. IMMUNOLOGICAL REVIEWS
- A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease
- (2017) Zhonge Chen et al. Lipids in Health and Disease
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- A Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLD
- (2016) Newaz Hossain et al. Gastroenterology Research and Practice
- Protective Role of Sylimarin on Methotrexate induced Hepato-nephrotoxicity in Children with Acute Lymphoblastic Leukemia
- (2016) Adel Abd Elhaleim Hagag Mediterranean Journal of Hematology and Infectious Diseases
- A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury
- (2015) Chote Luangchosiri et al. BMC Complementary and Alternative Medicine
- The Role of Oxidative Stress and Antioxidants in Liver Diseases
- (2015) Sha Li et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Efficacy of Lifestyle Changes in Subjects with Non-Alcoholic Liver Steatosis and Metabolic Syndrome May Be Improved with an Antioxidant Nutraceutical: A Controlled Clinical Study
- (2015) Gianpaolo Sorrentino et al. Drugs in research & development
- Effect and the probable mechanisms of silibinin in regulating insulin resistance in the liver of rats with non-alcoholic fatty liver
- (2013) Jiayin Yao et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Pathophysiology of NASH: Perspectives for a Targeted Treatment
- (2013) Fabio Marra et al. CURRENT PHARMACEUTICAL DESIGN
- Acute Liver Failure
- (2013) William Bernal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alterations in Sulfur Amino Acid Metabolism in Mice Treated with Silymarin: A Novel Mechanism of Its Action Involved in Enhancement of the Antioxidant Defense in Liver
- (2013) Do Kwon et al. PLANTA MEDICA
- Current Concepts and Management Approaches in Nonalcoholic Fatty Liver Disease
- (2013) Bashar M. Attar et al. TheScientificWorldJOURNAL
- Glutathione synthesis
- (2012) Shelly C. Lu BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Legalon® SIL: The Antidote of Choice in Patients with Acute Hepatotoxicity from Amatoxin Poisoning
- (2012) Ulrich Mengs et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Identification of novel mechanisms of silymarin on the carbon tetrachloride-induced liver fibrosis in mice by nuclear factor-κB bioluminescent imaging-guided transcriptomic analysis
- (2012) Chia-Cheng Li et al. FOOD AND CHEMICAL TOXICOLOGY
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
- (2012) Naga Chalasani et al. HEPATOLOGY
- Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: Analysis of isolated hepatic stellate cells
- (2012) MINA KIM et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Amanita phalloidespoisoning
- (2011) Loren Keith French et al. CLINICAL TOXICOLOGY
- Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents
- (2011) Joel E. Lavine JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Role of nuclear factor κB in liver health and disease
- (2010) Stuart M. Robinson et al. CLINICAL SCIENCE
- The Effect of Lifestyle Changes in Non-Alcoholic Fatty Liver Disease
- (2010) Elena Centis et al. DIGESTIVE DISEASES
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Silymarin suppress CD4+ T cell activation and proliferation: Effects on NF-κB activity and IL-2 production
- (2010) Marjan Gharagozloo et al. PHARMACOLOGICAL RESEARCH
- Milk thistle in liver diseases: past, present, future
- (2010) Ludovico Abenavoli et al. PHYTOTHERAPY RESEARCH
- Oxidative stress and antioxidants in hepatic pathogenesis
- (2010) Hye-Lin Ha WORLD JOURNAL OF GASTROENTEROLOGY
- A randomized, controlled, double-blind, pilot study of milk thistle for the treatment of hepatotoxicity in childhood acute lymphoblastic leukemia (ALL)
- (2009) Elena J. Ladas et al. CANCER
- Alcoholic liver disease
- (2009) Robert S. O'Shea et al. HEPATOLOGY
- Silymarin Ascending Multiple Oral Dosing Phase I Study in Noncirrhotic Patients With Chronic Hepatitis C
- (2009) Roy L. Hawke et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells
- (2009) Marco Trappoliere et al. JOURNAL OF HEPATOLOGY
- A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis
- (2009) Samer S. El-Kamary et al. PHYTOMEDICINE
- Nuclear factor kappa B and hepatitis viruses
- (2008) Yong-Song Guan et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- NF-κB in liver diseases: a target for drug therapy
- (2008) Pablo Muriel JOURNAL OF APPLIED TOXICOLOGY
- Assessment of drug–drug interaction for silymarin
- (2008) Johannes Doehmer et al. TOXICOLOGY IN VITRO
- An Updated Systematic Review with Meta-Analysis for the Clinical Evidence of Silymarin
- (2008) R. Saller et al. FORSCHENDE KOMPLEMENTARMEDIZIN
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search